z-logo
open-access-imgOpen Access
Small Bowel Adenocarcinoma Complicating Coeliac Disease: A Report of Three Cases and the Literature Review
Author(s) -
Hafida Benhammane,
Fatima Zahra Mrabet,
Karima Idrissi Serhouchni,
Mounia El Yousfi,
Ilias Charif,
Imane Toughray,
Naoufal Mellas,
Afaf Amarti,
Khalid Maazaz,
Sidi Adil Ibrahimi,
Omar El Mesbahi
Publication year - 2012
Publication title -
case reports in oncological medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.173
H-Index - 7
eISSN - 2090-6714
pISSN - 2090-6706
DOI - 10.1155/2012/935183
Subject(s) - medicine , oxaliplatin , coeliac disease , capecitabine , malignancy , gastroenterology , disease , adenocarcinoma , adjuvant chemotherapy , chemotherapy , epidemiology , colorectal cancer , cancer , breast cancer
Coeliac disease is associated with an increased risk of malignancy, not only of intestinal lymphoma but also of small intestinal adenocarcinoma which is 82 times more common in patients with celiac disease than in the normal population. We report three additional cases of a small bowel adenocarcinoma in the setting of coeliac disease in order to underline the epidemiological features, clinicopathological findings, and therapeutic approaches of this entity based on a review of the literature. The three patients underwent a surgical treatment followed by adjuvant chemotherapy based on capecitabine/oxaliplatin regimen, and they have well recovered.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom